Literature DB >> 14573674

Comparative pathogenicity of Escherichia coli O157 and intimin-negative non-O157 Shiga toxin-producing E coli strains in neonatal pigs.

Evelyn A Dean-Nystrom1, Angela R Melton-Celsa, Joachim F L Pohlenz, Harley W Moon, Alison D O'Brien.   

Abstract

We compared the pathogenicity of intimin-negative non-O157:H7 Shiga toxin (Stx)-producing Escherichia coli (STEC) O91:H21 and O104:H21 strains with the pathogenicity of intimin-positive O157:H7 and O157:H(-) strains in neonatal pigs. We also examined the role of Stx2d-activatable genes and the large hemolysin-encoding plasmid of O91:H21 strain B2F1 in the pathogenesis of STEC disease in pigs. We found that all E. coli strains that made wild-type levels of Stx caused systemic illness and histological lesions in the brain and intestinal crypts, whereas none of the control Stx-negative E. coli strains evoked comparable central nervous system signs or intestinal lesions. By contrast, the absence of intimin, hemolysin, or motility had little impact on the overall pathogenesis of systemic disease during STEC infection. The most striking differences between pigs inoculated with non-O157 STEC strains and pigs inoculated with O157 STEC strains were the absence of attaching and effacing intestinal lesions in pigs inoculated with non-O157:H7 strains and the apparent association between the level of Stx2d-activatable toxin produced by an STEC strain and the severity of lesions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573674      PMCID: PMC219560          DOI: 10.1128/IAI.71.11.6526-6533.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Shiga-like toxin-producing Escherichia coli O111 and associated hemolytic-uremic syndrome: a family outbreak.

Authors:  N Banatvala; M M Debeukelaer; P M Griffin; T J Barrett; K D Greene; J H Green; J G Wells
Journal:  Pediatr Infect Dis J       Date:  1996-11       Impact factor: 2.129

2.  Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves.

Authors:  E A Dean-Nystrom; B T Bosworth; W C Cray; H W Moon
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

3.  A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens.

Authors:  T K McDaniel; K G Jarvis; M S Donnenberg; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

4.  Escherichia coli O157:H7 requires intimin for enteropathogenicity in calves.

Authors:  E A Dean-Nystrom; B T Bosworth; H W Moon; A D O'Brien
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection.

Authors:  S Tzipori; F Gunzer; M S Donnenberg; L de Montigny; J B Kaper; A Donohue-Rolfe
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells.

Authors:  M L McKee; A R Melton-Celsa; R A Moxley; D H Francis; A D O'Brien
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model.

Authors:  S W Lindgren; A R Melton; A D O'Brien
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates.

Authors:  D Piérard; G Muyldermans; L Moriau; D Stevens; S Lauwers
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

9.  Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice.

Authors:  A R Melton-Celsa; S C Darnell; A D O'Brien
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

Review 10.  Food-related illness and death in the United States.

Authors:  P S Mead; L Slutsker; V Dietz; L F McCaig; J S Bresee; C Shapiro; P M Griffin; R V Tauxe
Journal:  Emerg Infect Dis       Date:  1999 Sep-Oct       Impact factor: 6.883

View more
  16 in total

1.  Escherichia coli O157:H7 does not require intimin to persist in pigs.

Authors:  Dianna M Jordan; Sheridan L Booher; Harley W Moon
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

2.  Association of virulence genotype with phylogenetic background in comparison to different seropathotypes of Shiga toxin-producing Escherichia coli isolates.

Authors:  Jean Pierre Girardeau; Alessandra Dalmasso; Yolande Bertin; Christian Ducrot; Séverine Bord; Valérie Livrelli; Christine Vernozy-Rozand; Christine Martin
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

3.  Shiga-toxigenic Escherichia coli-inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome.

Authors:  J F Pohlenz; K R Winter; E A Dean-Nystrom
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Enhanced surveillance of non-O157 verotoxin-producing Escherichia coli in human stool samples from Manitoba.

Authors:  Laura H Thompson; Sandra Giercke; Carole Beaudoin; David Woodward; John L Wylie
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-11       Impact factor: 2.471

Review 5.  Shiga toxin-producing Escherichia coli in swine: the public health perspective.

Authors:  Marion Tseng; Pina M Fratamico; Shannon D Manning; Julie A Funk
Journal:  Anim Health Res Rev       Date:  2014-01-08       Impact factor: 2.615

6.  Invasion of epithelial cells by locus of enterocyte effacement-negative enterohemorrhagic Escherichia coli.

Authors:  Shelley N Luck; Vicki Bennett-Wood; Rachael Poon; Roy M Robins-Browne; Elizabeth L Hartland
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

7.  Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes.

Authors:  Kellie R K Winter; William C Stoffregen; Evelyn A Dean-Nystrom
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

8.  Human microbiota-secreted factors inhibit shiga toxin synthesis by enterohemorrhagic Escherichia coli O157:H7.

Authors:  Thibaut de Sablet; Christophe Chassard; Annick Bernalier-Donadille; Marjolaine Vareille; Alain P Gobert; Christine Martin
Journal:  Infect Immun       Date:  2008-12-08       Impact factor: 3.441

9.  Development of an experimental hemolytic uremic syndrome in rats.

Authors:  Elsa Zotta; Nestor Lago; Federico Ochoa; Horacio A Repetto; Cristina Ibarra
Journal:  Pediatr Nephrol       Date:  2008-02-06       Impact factor: 3.714

10.  Development of a simple latex agglutination assay for detection of shiga toxin-producing Escherichia coli (STEC) by using polyclonal antibody against STEC.

Authors:  Tapas K Hajra; Prasanta K Bag; Suresh C Das; Souryadeep Mukherjee; Asis Khan; T Ramamurthy
Journal:  Clin Vaccine Immunol       Date:  2007-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.